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Abstract
Background: The mechanism involved in the maintenance and differentiation of embryonic stem
(ES) cells is incompletely understood.
Results: To address this issue, we have developed a retroviral gene trap vector that can target
genes expressed in undifferentiated ES cells. This gene trap vector harbors both GFP and Neo
reporter genes. G-418 drug resistance was used to select ES clones in which the vector was
integrated into transcriptionally active loci. This was then followed by GFP FACS profiling to
identify ES clones with reduced GFP fluorescence and, hence, reduced transcriptional activity when
ES cells differentiate. Reduced expression of the GFP reporter in six of three hundred ES clones in
our pilot screening was confirmed to be down-regulated by Northern blot analysis during ES cell
differentiation. These six ES clones represent four different genes. Among the six integration sites,
one was at Zfp-57 whose gene product is known to be enriched in undifferentiated ES cells. Three
were located in an intron of a novel isoform of CSL/RBP-Jkappa which encodes the key transcription
factor of the LIN-12/Notch pathway. Another was inside a gene that may encode noncoding RNA
transcripts. The last integration event occurred at a locus that may harbor a novel gene.
Conclusion: Taken together, we demonstrate the use of a novel retroviral gene trap vector in
identifying genes preferentially expressed in undifferentiated ES cells.
Background
Stem cells offer hope of potential therapies for diseases as
disparate as diabetes, Parkinson's and Alzheimer's dis-
ease. Naturally, knowledge of the intrinsic properties of
stem cells must be gained before the hope of using stem
cells for therapeutic purposes becomes a reality. In partic-
ular it will be important to know how these cells that
retain the ability to continuously self-renew in a multipo-
tential state can be maintained in this undifferentiated
state.
There are more than a dozen different kinds of stem cells
in mammals, including those that retain the ability of
totipotential differentiation, the so-called embryonic
stem cells or pluripotential stem cells [1]. Recent data sug-
gest that some adult stem cells are more plastic than orig-
inally thought [1]. Not only can certain types of adult
stem cells be induced to differentiate along several cell lin-
eages (termed transdifferentiation), it has also been
observed that differentiated cells can be reverted to stem
cell-like cells (termed dedifferentiation) and redirected to
other cell lineages [2]. Although it has been recently
shown that cell fusion could provide an alternative expla-
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nation for the phenomenon of transdifferentiation [3,4],
it is still consistent with the notion that there are some key
regulators in stem cells that keep them in an undifferenti-
ated pluripotent state.
We are interested in identifying these determinants since
they are likely to play an important role in the mainte-
nance, proliferation, survival or differentiation of stem
cells. ES cells should express the determinants typical of
all stem cells. They can be easily maintained in culture and
are amenable to both genetic and molecular manipula-
tions. Thus, we have chosen to use mouse ES cells as a
model system in which to isolate determinants that main-
tain stem cells in their undifferentiated state or promote
the differentiation of stem cells into a certain lineage. One
assumption for such stem cell determinants is that at least
some are only expressed in undifferentiated stem cells,
but not in differentiated cells. Indeed, the Oct-4 and the
Nanog genes, both of which encode a homeodomain tran-
scription factor, are required for the establishment of the
undifferentiated state of ES cells and are rapidly down-reg-
ulated in differentiated cells [5-10]. The expression of
another transcription factor, Rex-1, also correlates with the
undifferentiated state of ES cells [11,12]. To identify addi-
tional genes that behave similarly to Oct-4, Nanog and
Rex-1, we have used a gene trap approach coupled with
GFP FACS analysis to screen for genes that are expressed
in undifferentiated ES cells, but dramatically down-regu-
lated in the differentiated cells. Among these genes, pre-
sumably some play an essential role as determinants of
the undifferentiated state or factors in promoting the dif-
ferentiation of ES cells into a particular lineage.
Gene trap is a genetic approach that utilizes promoter-less
reporters to target endogenous functional genes [13-16].
It could be either plasmid- or retrovirus-based. The advan-
tage of using a retroviral vector is that retroviral infection
normally results in a single integration event. We have
constructed a novel promoter-less retroviral gene trap vec-
tor harboring both GFP and Neo reporter genes that can
only be expressed when the vector is integrated into an
active endogenous gene. By utilizing this vector, coupled
with GFP FACS profiling of 300 ES clones, we have suc-
cessfully isolated 30 candidate clones that displayed less
GFP fluorescence when the ES cells differentiated. We
confirmed by RT-PCR or Northern blot analysis that the
genes trapped in six of the candidate ES clones were
down-regulated during ES cell differentiation.
The ease of using the gene trap approach and GFP FACS
profiling, plus the simplicity of identifying the trapped
genes, make this vector a suitable choice to target and iso-
late ES cell-specific genes in mice. Similar to previous
studies [17-22], it can be applied to other cell types to
identify developmentally regulated genes or genes that are
responsive to certain growth factors.
Results
Construction of a retroviral gene trap vector that allows 
GFP FACS profiling as well as G-418 drug selection
As a first step toward the goal of isolating ES cell-specific
genes, we designed a novel murine Moloney leukemia
virus (MMLV)-based retroviral gene trap vector. This vec-
tor harbors a strong splice acceptor (SA) site followed by
GFP and Neo reporter genes (Figure 1). The SA site is
derived from the intron 2/exon 3 region of Bcl-2 [23].
Each reporter is under the control of an independent
internal ribosome entry site (IRES) (Figure 1). The regula-
tory sequence in the U3 region of the 3'LTR was deleted
and replaced with a LoxP site which is duplicated upon
retrovirus-mediated integration. Most of the gene trap vec-
tor can be removed by Cre recombinase [23]. Upon
reverse transcription and retroviral integration, the U3
region of the 3'LTR is duplicated. Neither the 3'LTR nor
the 5'LTR of the integrated gene trap vector contained any
viral enhancer or promoter. Therefore, neither reporter is
expressed unless the vector is integrated into a transcrip-
tionally active endogenous gene. Due to the presence of
the SA site, reporters are co-transcribed as a single fusion
transcript after being directly spliced to an exon of a tran-
scribed endogenous gene that lies 5' to the inserted vector.
The GFP and Neo reporters are translated as two inde-
pendent protein products since the IRES sequence placed
immediately in front of each reporter gene can initiate
translation independent of the 5' upstream sequences of
the fusion transcript. Accordingly, the infected cells and
their progeny carrying this integrated vector display green
fluorescence as well as G-418 drug resistance. G-418 drug
resistance conferred by the expression of the Neo reporter
gene can be used to select for ES clones in which a tran-
scriptionally active endogenous gene has been targeted.
GFP fluorescence resultant from expression of the GFP
reporter gene allows us to screen for ES clones that display
significant down-regulation of green fluorescence upon
ES cell differentiation.
Isolation of ES clones in which the trapped genes are 
down-regulated during ES cell differentiation
The schematic procedure used to isolate candidate ES
clones is illustrated in Figure 2A. Viral supernatant of this
gene trap vector was harvested from phoenix packaging
cells [24] and directly applied onto TC1 mouse ES cells
grown on a layer of feeder fibroblast cells. After selection
with 260 µg/ml of G-418 for 10 days, approximately 10–
20 resistant colonies were obtained from a 10-cm dish.
These clones were picked individually and transferred into
a 24-well plate seeded with feeder fibroblast cells. In total
we picked about 300 independent ES clones in a pilot
screening experiment.BMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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If the endogenous gene is turned off when ES cells differ-
entiate, the expression of GFP and Neo reporters in the
trapped locus will not persist and these cells will lose both
green fluorescence and drug resistance. We have taken
advantage of one of the conspicuous traits of ES cells; they
have the tendency to spontaneously differentiate. In the
presence of feeder fibroblast cells and leukemia inhibitory
factor (LIF), a significant fraction of ES cells remain undif-
ferentiated. By contrast, almost all ES cells become differ-
entiated within four days without feeder fibroblast cells
and LIF. Two populations of cells were derived for each ES
clone: undifferentiated cells grown in the presence of
feeder fibroblast cells and LIF or differentiated cells grown
without either feeder fibroblast cells or LIF. These two
populations of cells were compared for each ES clone for
the level of GFP fluorescence by FACS profiling.
About three hundred ES clones were screened to identify
those that displayed significant reduction in GFP fluores-
cence when differentiated. About 40% of the G-418-resist-
ant ES clones we examined did not show any fluorescence
in FACS analysis. We reasoned that enzyme-based drug
selection is more sensitive than GFP fluorescence and thus
not all G-418-resistant ES clones displayed GFP fluores-
cence. For the rest of the ES clones, expression of the GFP
reporter appeared to remain unchanged in most ES clones
when comparing undifferentiated cells and their differen-
tiated counterparts. For example, in the ES clone 5B33
very little difference in GFP fluorescence was detected
between the undifferentiated and differentiated popula-
tions of cells (Figure 2B, left panel). Nevertheless, about
30 out of 300 ES clones screened exhibited significant
down-regulation of GFP expression by FACS analysis. The
highly GFP-positive portion of the cells from the undiffer-
entiated sample of the ES clone 5C1 was almost com-
pletely missing in the differentiated sample (Figure 2B,
right panel).
Confirming the down-regulation of the candidate ES 
clones at the transcript level by Northern blot
The intensity of GFP fluorescence of every ES clone as well
as the degree of down-regulation in GFP FACS profiles
upon ES cell differentiation varied greatly among these
candidate clones. To confirm that down-regulation of GFP
fluorescence reflects decreased transcription of the GFP
reporter gene, we resorted to Northern blot analysis to
examine these candidate ES clones directly at the tran-
script level with a GFP cDNA fragment as the probe (Fig-
ure 3 and Supplemental Figure S1, see Additional file 1).
Except for the ES clone 5A3, 1B6 and 6A29, the rest of 22
ES clones shown on Northern blotting displayed signifi-
cant reduction of GFP fluorescence in FACS profiling as
exemplified by the ES clone 5C1 (Figure 2B) and 5C32
(Supplemental Figure S2, see Additional file 1). We used
an ES clone harboring a REX-1::EGFP transgene as the
positive control in which the expression of the GFP
reporter gene is under the control of Rex-1  regulatory
sequences [25,26]. We found that this ES clone underwent
the expected reduction of GFP fluorescence during ES cell
differentiation based on GFP FACS analysis (data not
shown). Indeed, the GFP transcript expressed in these ES
clones was also reduced in the differentiated cells versus
the undifferentiated cells (compare Lane 20 with Lane 19
in Figure 3). Similar to the ES clone transfected with the
REX-1::EGFP reporter construct, the amount of fusion
transcript appeared to be down-regulated in the trapped
ES clone 5C1 and 2G2 as shown in Figure 3 (compare
Lanes 13, 14 with Lanes 11, 12 and Lane 18 with Lane 17).
In fact, transcription of the gene trapped in the ES clone
2G2 appeared to be completely shut off when ES cells dif-
Diagram of the gene trap vector eGeoN/E+pA Figure 1
Diagram of the gene trap vector eGeoN/E+pA. Neo, Neo resistance gene; GFP, cDNA encoding green fluorescent pro-
tein; pA, polyA addition signal derived from the gene of bovine growth hormone (bGH); SA, splice acceptor sequence present 
in intron 2/exon 3 of Bcl-2; I(E), IRES sequence from encephalomyocarditis virus (EMCV); I(N), IRES sequence from the 5' UTR 
region of the NF-kappaB repressing factor (NRF) gene; 3'LTR and 5'LTR, long terminal repeat regions of the RET vector modi-
fied from murine Moloney leukemia virus [23]. Both 3'LTR and 5'LTR are comprised of U5, R and U3. The regulatory sequence 
in the U3 region of 3'LTR was deleted and replaced with a loxP site which could be recognized by Cre recombinase.
SA I(N) GFP I(E) Neo pA
5￿ LTR 3￿ LTR
LoxP
U5 U3
R
U5 U3
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G-418 drug resistance and GFP fluorescence were used to isolate the trapped ES clones whose trapped genes are down-regu- lated during ES cell differentiation Figure 2
G-418 drug resistance and GFP fluorescence were used to isolate the trapped ES clones whose trapped genes 
are down-regulated during ES cell differentiation. (A) Flow chart for the experimental procedure.(B) GFP FACS profil-
ing of the ES clones. FACS plots of the ES clone 5B33 (left panel) and ES clone 5C1 (right panel) are shown with both the undif-
ferentiated populations of cells (the green filled histograms) and differentiated populations of cells (the red unfilled histograms). 
Undifferentiated ES cells were grown in the presence of LIF and feeder fibroblast cells and the differentiated cells were grown 
without LIF and feeder fibroblast cells. "P" marks the GFP-positive population of ES cells present in the undifferentiated cells of 
the ES clone 5C1.
Infection of ES cells
Picking gene-trapped ES clones
Screening by GFP FACS analysis
Conﬁrming transcriptional down-
regulation of GFP by Northern blot
A
B
5B33 5C1
Identifying trapped genes by inverse PCR
Verifying down-regulation of endogenous genes
GFP Fluorescence
Cell # PBMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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ferentiated. Overall, six ES clones out of 30 candidate ES
clones were confirmed to display down-regulation of the
reporter genes at the transcript level (Figure 3 and Supple-
mental Figure S1, see Additional file 1) and they are illus-
trated in Table 1.
Determining the molecular identities of genes trapped in 
the candidate ES clones
To determine the molecular identities of the trapped
genes, we used an inverse PCR approach to isolate the ret-
roviral integration site of these candidate ES clones
together with the flanking genomic sequence (data not
Table 1: Illustration of the trapped genes proven to be 
significantly down-regulated in the differentiated ES cells versus 
undifferentiated ES cells
Trapped ES 
clone
Matched Gene EST Origin
2G2, 5C25, 
6B13
A novel CSL 
isoform
Eight-cell embryo, Germ cell, 
ES cell
5C1 Zfp-57 Embryo, Germ cell, ES cell
5C11 Novel Blastocyst, ES cell
4B1 Unknown
Northern blot analysis of the candidate ES clones Figure 3
Northern blot analysis of the candidate ES clones. (A) The exposed X-ray film of the Northern blot with a GFP cDNA 
fragment as the probe. U, Undifferentiated ES cell population. D, Differentiated ES cell population. TC1, wild-type ES cells. 
REX-1, an ES clone with the REX1::EGFP reporter transgene. 5C32, 5C18, 5C1, 5A3 and 2G2 are gene-trapped ES clones iso-
lated in this study. (B) The RNA-agarose gel under an ultraviolet (UV) lamp. Approximately 10 µg of total RNA was loaded for 
the U and D samples of the control samples and each ES clone, except that 5 µg of total RNA was applied for the ES clone 5A3 
and 2G2. The positions of 18S and 28S ribosomal RNAs on the agrose gel are marked.
TC1 5C32 5C18 5C1 5A3 2G2 REX-1
 U  D  U  U  D  D  U U  D  D U  U  D   D  U  D U D  U  D
28S
18S
Lane 1 2 3 4  5  6  7 8  9 10  11 12 13 141516  1718 19 20
A
B Lane 1 2 3 4  5  6  7 8  9 10  11 12 13 141516  1718 19 20BMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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shown). This genomic sequence was used to search the
available genome databases. Indeed, we identified the
integration site for 15 out of 19 candidate ES clones
shown in Figure 3 and Supplemental Figure S1 (see Addi-
tional file 1) which displayed significant down-regulation
of GFP fluorescence by FACS analysis when differentiated
and they are illustrated in Table 1 and Table 2. Out of the
six ES clones that displayed significant down-regulation of
the reporter expression in both GFP FACS profiling and
Northern blotting, we were able to match all the integra-
tion sites to the mouse genome sequence and predict the
correspondingly trapped genes in five of the six ES clones
(Table 1).
One clone resulted from integration in the gene Zfp-57.
This gene was previously isolated in a screen for genes that
were expressed in undifferentiated teratocarcinoma F9
cells but down-regulated upon treatment of F9 cells with
retinoic acid [27]. In agreement with our studies, Zfp-57
was also found to be expressed in ES cells and down-reg-
ulated when differentiated into neurons [28-30]. It
encodes a basic protein with multiple zinc fingers and is
predominantly localized to the nucleus [27]. Similar to
the findings described in a recent paper [30,31], we also
found that ZFP-57 contains a putative KRAB box (Li,
Youngson, Zhou, Ito, Ferguson-Smith and Leder, unpub-
lished data).
The integration sites for three independent clones were
localized to the same genomic locus. Indeed, the gene trap
vector was inserted into the same huge intron but at dif-
ferent locations of a novel isoform of CSL/RBP-Jkappa (see
Figure 5A below) encoding the key transcription factor of
the LIN-12/Notch pathway [32]. This isoform differs from
other isoforms by using a transcriptional initiation site
considerably upstream of those used by the other iso-
forms. The integration sites for these three ES clones are
located in the first intron of this novel isoform (see Figure
5A below). Based on genomic databases, EST clones
matching this isoform were found to be present in eight-
cell embryos, embryonic germ cells and embryonic stem
cells.
The gene trapped in the fifth ES clone matches two EST
clones that are expressed in the blastocyst. Analysis of
cDNAs for this gene suggests the presence of multiple
alternatively spliced isoforms with the characteristics of
noncoding RNA molecules (see below).
The identity of the gene trapped in the last ES clone, which
was confirmed to be down-regulated when ES cells differ-
entiate, remains to be determined.
Confirming the identities of the candidate genes by RT-
PCR
To confirm the identities of the predicted genes trapped in
the candidate ES clones, we resorted to RT-PCR analysis of
the transcriptional fusion products between the trapped
gene and the gene trap vector. This was performed using
one primer complementary in sequence to the exon 3
region of Bcl-2 found in the gene trap vector and the other
one corresponding to the upstream exon of the predicted
trapped endogenous gene. In every case, the expected
fusion products were obtained for each ES clone from the
reverse transcriptase (RT)-treated samples, but not from
negative control samples (Figure 4A, compare, for exam-
ple, Lanes 2 and 3 for the clone 2G2). Thus, the predicted
trapped genes were confirmed for these candidate ES
clones.
Sequencing of these fusion RT-PCR products not only
confirmed our prediction for these trapped genes, but also
provided us with the opportunity to observe the exact
splicing patterns of fusion transcripts around the integra-
tion site. As shown schematically in Figure 4, there are
basically three types of transcripts generated depending
on whether the integration occurred in an intron or into
an exon. When the integration site was localized in an
intron of the endogenous gene (Figure 4B), as was the case
in the ES clone 2G2 and 5C25, a completely spliced fusion
transcript was observed due to the presence of the nearby
splice donor sequence at the junction of the exon N and
intron N which acted as the donor to the strong splice
acceptor site in front of the IRES-EGFP reporter. However,
when the gene trap vector was inserted into an exon of the
endogenous gene as was observed in the ES clone 5C1
(Figure 4C), two kinds of transcripts were produced: a
read-through fusion transcript and a partially spliced
fusion transcript. The read-through fusion transcript
includes the 5' portion of the interrupted exon (Exon N-
5') of the endogenous gene, the 3'LTR region, the SA
region and the reporters. The partially spliced fusion tran-
script was generated when the cryptic splice donor site
present in the 3'LTR was utilized to promote splicing of
the 5' portion of the interrupted exon (Exon N-5') along
with a portion of the 3'LTR in the splice acceptor site in
front of the reporters. No matter whether the gene trap
vector is inserted into an intron or an exon, fusion tran-
scripts will be generated and both GFP and neo reporter
genes will be translated as two independent protein prod-
ucts due to the presence of an IRES sequence in front of
each reporter gene.
Verification of the down-regulation of the endogenous 
genes
We employed either Northern blot with gene-specific
probes or semi-quantitative RT-PCR to test if the expres-
sion of the endogenous genes behaves similarly to that ofBMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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the GFP reporter gene in the correspondingly trapped ES
clones.
We utilized a semi-quantitative RT-PCR approach to
investigate the novel embryonic isoform of CSL/RBP-Jka-
ppa trapped in the ES clone 2G2, 5C25 and 6B13. Four
strategies were used: two primers specific to the embry-
onic isoform (I of Figure 5B), or two primers common to
all isoforms (II of Figure 5B), or one primer specific to the
embryonic isoform and the other common to all isoforms
(III of Figure 5B), or one primer specific to the most com-
mon and ubiquitously expressed isoform and the other
common to all the isoforms (IV of Figure 5B). In either
strategy I or III, when at least one primer is specific to the
particular embryonic isoform, a relatively bright band of
the expected molecular weight was seen on the agarose gel
for the RT-PCR products amplified from two independent
total RNA samples (1U and 2U in Figure 5B) of undiffer-
entiated wild-type ES cells. In contrast, only a minimal
amount of product was amplified from two correspond-
ing samples obtained from differentiated cells (1D and
2D in Figure 5B). As expected, similar amounts of ampli-
fied product were obtained from the corresponding sam-
ples when either all the isoforms were amplified (II of
Figure 5B) or only the most common one was amplified
(IV of Figure 5B). Thus, it appears that this novel embry-
onic isoform of CSL/RBP-Jkappa is preferentially expressed
in the undifferentiated ES cells.
Transcriptional down-regulation of the novel gene
trapped in the ES clone 5C11 was verified by Northern
blot using a gene-specific probe (Figure 5C). Three inde-
pendent total RNA samples were derived from both the
undifferentiated (Lanes 1, 2 and 5 of Figure 5C) as well as
the differentiated (Lanes 3, 4 and 6 of Figure 5C) wild-
type ES cells. Clearly, many more transcripts were present
in all the samples prepared from the undifferentiated ES
cells than those from the differentiated cells.
In agreement with published findings [27,28,30], we also
confirmed the down-regulation of Zfp-57 trapped in the
ES clone 5C1 by Northern blot when ES cells differentiate
(data not shown).
The novel gene trapped in the ES clone 5C11 may be a 
non-coding RNA gene with a very restricted expression 
pattern
Interestingly, transcripts derived from the novel gene
trapped in the ES clone 5C11 appeared to be very hetero-
geneous with multiple transcription initiation sites, mul-
tiple polyA-addition signals and multiple alternative
splicing patterns (Li and Leder, unpublished data). The
main transcripts were apparently very large based on their
positions relative to those of the ribosomal RNA tran-
scripts (Figure 5B). However, a lot of the full-length
cDNAs we isolated from the ES cells with 5' RACE and 3'
RACE were around 500 bp in size. These cDNAs may cor-
respond to the transcripts of lower molecular weights in
the indicated region of Figure 6A when the same Northern
blot shown in Figure 5C was subjected to longer exposure.
These transcripts also appeared to be down-regulated dur-
ing ES cell differentiation (Figure 6A). Intriguingly, these
short full-length RNA molecules were predicted to form
very stable secondary structures as exemplified by one of
the RNA molecules (Figure 6B and Figure 6C). Consistent
with its expression in the undifferentiated ES cells, several
EST clones corresponding to this locus were derived from
early blastocysts. However, no transcripts were detected
by Northern blot in any major adult mouse organ (Figure
6D). Thus, this novel gene appears to be primarily
expressed in the undifferentiated ES cells and blastocysts.
Discussion
As has previously been shown, it is certainly possible to
use a genomic approach to identify ES cell-specific genes
at a much larger scale [33,34]. DNA micro-array as well as
serial analysis of gene expression (SAGE) has been widely
used in a variety of model systems. However, the retroviral
gene trap approach has the advantage of being mutagenic,
allowing us to directly evaluate the function of the genes
in vivo. In addition, as demonstrated here and in other
studies [20,35], this strategy can identify both novel genes
as well as novel isoforms of known genes. For example, we
have identified a novel embryonic isoform of CSL/RBP-
JKappa. By contrast, DNA micro-array is based on known
genes and available EST databases. SAGE analysis can gen-
erate previously unknown tags, but it is based on a short
Table 2: Illustration of ES clones that display significant down-regulation in FACS profiling but could not be confirmed by Northern 
blot
Trapped ES clone Matched gene (or genomic region)
5C32, 5C18 M96
5B1, 5B5, 5B20, 5A8 CTBP2
2F1 (2 integrations) UBA52 and LYSMD1
4A8 LYSMD1
5B39 Near CXXC6BMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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The identities of the trapped genes were verified by RT-PCR analysis of the fusion transcripts Figure 4
The identities of the trapped genes were verified by RT-PCR analysis of the fusion transcripts. (A) RT-PCR prod-
ucts of the four candidate ES clones (2G2, 5C25, 5C11 and 5C1). The primer Xho-Junc (P1), which has a sequence comple-
mentary to the junction of the SA site and I(N) sequence in the gene trap vector eGeoN/E+pA, was used for reverse 
transcription in the first-strand cDNA synthesis. Another primer Bcl-2R2 (P2) complementary to exon 3 of Bcl-2 in eGeoN/
E+pA was paired with the gene-specific primer (P3) to amplify the cDNAs derived from the fusion transcripts between the 
endogenous trapped genes and the gene trap vector. The positions of these primers (P1, P2, P3) with respect to the gene trap 
vector and the trapped endogenous genes are indicated in Figure 4B and Figure 4C. Arrows indicate the agarose gel positions 
of the expected RT-PCR products. "+", reverse transcriptase (RT) was included in the first-strand cDNA synthesis (Lanes 2, 4, 
6, 8). "-", no reverse transcriptase was added to the first-strand cDNA synthesis (Lanes 3, 5, 7, 9). Lane 1 and Lane 11, 1kb plus 
DNA ladder (Invitrogen/Gibco). (B) Schematic diagrams illustrating the fusion transcripts expressed in the trapped ES clones 
when the gene trap vector is inserted into an intron of the active endogenous genes (e.g. ES clone 2G2 and 5C25). As shown 
in the diagrams, the vector is inserted into the Intron N between Exon N and Exon N+1. After the splicing of the fusion tran-
scripts, the splice donor present at the junction of Exon N/Intron N was utilized to join the Exon N directly to the splice 
acceptor (SA) present in front of the GFP and Neo reporter genes. (C) Schematic diagrams illustrating the fusion transcripts 
expressed in the trapped ES clones when the gene trap vector is integrated into an exon of the active endogenous genes (e. g. 
ES clone 5C1, the first exon of Zfp-57). As shown in the diagrams, the vector is integrated into Exon N, which results in the 
split of Exon N into two parts (Exon N-5' and Exon N-3'). A read-through fusion transcript will be generated or the cryptic 
splice donor site present in the 3'LTR of the vector is utilized to join the Exon N-5' part and portion of the 3'LTR directly to 
the splice acceptor (SA) present in front of the GFP and Neo reporter genes.
B
C
Neo Intron N-5’
Exon N+1
3￿ LTR 5￿ LTR
Exon N
Exon N
Exon N-5￿ Exon N-3￿
A ES clone      2G2  5C25  5C11  5C1
RT                 +   -    +   -   +   -   +    -
Lane  1   2   3 4   5   6   7   8   9  10
2G2, 5C25
5C11
5C1
5C1
P1 P2
P3 Intron N-3’ Trapped
Locus
Transcript
GFP SA
Neo GFP SA
AAAAAA
3￿ LTR 5￿ LTR P1 P2
Trapped
Locus
P3 Neo GFP SA
3￿ LTR
AAAAAA
Neo GFP SA Exon N-5￿
Exon N-5￿ Neo GFP SA
AAAAAA
TranscriptBMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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Verifying the down-regulation of the endogenous genes during ES cell differentiation Figure 5
Verifying the down-regulation of the endogenous genes during ES cell differentiation. (A) Diagrams are shown for 
the 5' portion of the novel embryonic isoform (upper, 2G2) as well as the most common isoform (lower, CSL) of CSL/RBP-Jka-
ppa. The first exon (Exon N) of the novel embryonic isoform is located upstream of the second exon (Exon 2) which is com-
mon to all known isoforms. The predicted initiation codon "ATG" is indicated above the first exons and the primers (P1, P2, 
P3, P4 and P5) used in the semi-qauntitative PCR analysis below (Figure 5B) are also shown. "Int" stands for the retroviral inte-
gration site in the ES clone 2G2, which is located within the first intron of the novel embryonic isoform. Retroviral integration 
occurred in the same intron for two other ES clone 5C25 and 6B13. (B) Verification of the reduced expression of the novel 
early embryonic isoform of CSL/RBP-Jkappa in the differentiated cells (D) versus undifferentiated (U) cells by quantitative RT-
PCR analysis. 1U and 2U, two independent total RNA samples from the undifferentiated wild-type ES cells. 1D and 2D, two 
independent total RNA samples from the differentiated cells. Equal amounts of total RNA was applied to every PCR reaction in 
each primer set. Four different primer sets (I, II, III, IV) were used in this quantitative PCR analysis. I, both primers (P1 and P2) 
are derived from the first exon unique to this novel isoform (Figure 5A). II, both primers (P3 and P4) are common to all the 
isoforms of CSL/RBP-Jkappa. III, the forward primer (P1) is derived from the first exon and the reverse primer (P4) is comple-
mentary in sequence to the second exon, which is common to all isoforms of CSL/RBP-Jkappa. IV, the forward primer (P5) cor-
responds to the first exon of the most common isoform of CSL/RBP-Jkappa and the reverse primer (P4) is complementary in 
sequence to the common second exon. "+RT" indicates that reverse transcriptase (RT) was included in the first-strand cDNA 
synthesis. "-RT" indicates negative controls in which no reverse transcriptase was added in the first-strand cDNA synthesis. (C) 
Confirming the down-regulation of the novel gene trapped in the ES clone 5C11 by Northern blot with a gene-specific probe. 
Total RNA samples were derived from three independent populations (Lanes 1, 2, 5) of the undifferentiated (U) wild-type ES 
cells and three independent populations (Lanes 3, 4, 6) of the differentiated (D) wild-type ES cells. The gel positions of 18S and 
28S ribosomal RNA transcripts are marked with arrows.
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The novel gene trapped in 5C11 may encode noncoding RNA transcripts with a very restricted expression pattern Figure 6
The novel gene trapped in 5C11 may encode noncoding RNA transcripts with a very restricted expression pat-
tern. (A) Longer exposure (10-day) of the Northern blot as shown in Figure 5B revealed the presence of short transcripts of 
5C11. These heterogeneous short transcripts, marked by a bracket, were also down-regulated during ES cell differentiation by 
comparing Lanes 1, 2, 5 with Lanes 3, 4, 6. (B) Short transcripts of 5C11 were predicted to form very stable secondary struc-
tures. The nucleic acid folding program (mfold) was used for the prediction [47]. One predicted folded RNA structure for a 
full-length cDNA is shown here as an example. (C) A diagram is shown for the exon-intron organization of one of the isoforms 
of 5C11 transcripts. "Int" stands for the retroviral integration site in the ES clone 5C11. This isoform is predicted to form 
highly stable secondary structures (Figure 6B). (D) 5C11 transcripts are not detectable in any adult mouse organs by Northern 
blot. Total RNA samples were derived from the following adult mouse organs: Br, Brain; H, Heart; IN, Intestine; K, Kidney; Li, 
Liver; Lu, Lung; O, Ovary; S, Spleen; Te, Testis; Th, Thymus; U, Uterus. Total RNA was also derived from wild-type TC1 ES 
cells (TC1). The gel positions of the ribosomal RNA transcripts were marked.
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stretch of nucleotides at the 3'-end of a transcript and
sometimes it is difficult to unequivocally locate the corre-
sponding genes by simply searching the genome data-
bases. The ability to identify novel tags in the SAGE
analysis is limited by the abundance of the transcripts of a
given gene. In the case of the novel embryonic isoform of
CSL/RBP-Jkappa pulled out from our screen, it is unlikely
that it would be discovered from the SAGE analysis of ES
cells since it differs from other isoforms only at the
extreme 5' exon. The DNA micro-array approach may also
fail to identify this novel isoform unless oligonucleotides
corresponding to this extreme 5' exon were included in
the array.
The gene trap approach has its limitations. First, it is not
designed as a large-scale approach as is DNA micro-array
or SAGE and is limited by the efficiency of the vector to
trap the endogenous genes. Second, although retroviral
integrations are generally thought to be random, it
appears that there are some hotspots for murine Moloney
leukemia virus (MMLV) and other retroviruses [36]. It is
possible that these drawbacks could be partially overcome
by screening more ES clones.
The infection efficiency that was achieved with our current
vector was still quite low based on the number of G418-
resistant colonies obtained from a 10-cm dish of ES cells
infected with this vector. It is true that ES cells are notori-
ously difficult to infect and normally their infection effi-
ciencies are two to three orders of magnitude lower than
those of fibroblast cells [37]. It is possible that we could
increase the infection efficiencies by using VSVG pseudo-
typing which has been shown to be very effective in lenti-
viral vector-based infection of ES cells [38].
We favor our current reporter system expressing GFP and
Neo as two independent proteins over a bi-functional
reporter system involving the fusion of GFP and Neo
reporter genes because we found that expression of the
fused GFP and Neo reporter gene that we constructed is
toxic to the cells even without G-418 drug selection (Sup-
plemental Figure S3, see Additional file 1). Consistent
with this, it was reported that a fusion protein consisting
of GFP and Neo reporter genes displayed no visible GFP
fluorescence although it had sufficient Neo activity [39].
We noticed that roughly one-fifth of the ES clones that
had significant reduction of GFP fluorescence in FACS
profiling were verifiable by Northern blot. One plausible
reason for this is that FACS measures GFP fluorescence at
the single cell level whereas Northern blot is based on the
approximation of loading equal amount of total RNA
derived from a group of cells. In this case undifferentiated
ES cells proliferate very rapidly and it is likely that more
ribosomal and other RNA transcripts involved in protein
synthesis are produced in a given undifferentiated ES cell
than are produced in a differentiated cell. Therefore, we
may have under-estimated the amount of GFP reporter
transcripts in the undifferentiated cells on a per cell basis
by Northern blot. Another possible explanation is that the
degree of reduction in GFP fluorescence varied greatly
among the candidate ES clones. Indeed, almost all the
clones that were verifiable by Northern blot were the ones
that displayed dramatic down-regulation in FACS profil-
ing when ES cells became differentiated.
It is also possible to carry out a similar screening in ES
cells by using the well-established promoter-trap vectors
containing a beta-geo marker gene encoding a β-galactos-
idase and Neo fusion protein, in combination with a
fluorogenic  β-galactosidase substrate [13,20,21,35,40].
However, it is much easier to detect GFP fluorescence by
FACS and GFP fluorescence intensity is directly correlated
with the amount of GFP protein produced in a given cell.
In addition, the gene for β-galactosidase is much bigger
than that of GFP. This may cause a big drop in the viral
titer, hence the infection efficiency, due to the increased
size of the corresponding insert. On the other hand, infec-
tion efficiency is important for retrovirus-based screening
in ES cells for the reasons discussed above. Therefore, we
prefer our current reporter system for gene trap-based
screening in ES cells.
The novel embryonic isoform of CSL/RBP-Jkappa is very
specific to undifferentiated ES cells. It is almost absent in
differentiated cells. Other isoforms of CSL/RBP-Jkappa are
generally thought to be ubiquitously expressed except that
RBP-2N was highly enriched in the pre-B cell line 38B9
[41]. Interestingly, it was reported before that two mono-
clonal antibodies against CSL/RBP-Jkappa only stained the
undifferentiated ES cells but not differentiated cells [42].
It remains to be determined whether the protein that
these two monoclonal antibodies recognize corresponds
to another isoform (or the same isoform identified in this
study) of CSL/RBP-Jkappa expressed only in the undiffer-
entiated ES cells. It is also intriguing that CSL/RBP-Jkappa
and LIN-12/Notch signaling are involved in the generation
and maintenance of definitive neural stem cells [43,44]. It
is possible that this novel embryonic isoform of CSL/RBP-
Jkappa may play a similar role in generation or mainte-
nance of certain stem cells during embryonic develop-
ment.
Conclusion
ES cells share many characteristics with other somatic
stem cells. They all have self-renewal and multipotential
capacities. Many aspects of stem cell biology using ES cells
will probably be applicable to other stem cells as well.
However, unlike some other stem cells, ES cells can be
readily maintained in culture and are amenable to geneticBMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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and molecular manipulations. The ability to generate
germline transmissible mice from ES cells also gives us the
unique opportunity to look into the phenotypes in vivo.
The usefulness of this gene trap vector is manifested by its
application in targeting the functional endogenous locus
as well as introducing GFP and Neo reporters at the same
locus (Li and Leder, unpublished data). The presence of
the GFP reporter allows us to analyze the expression pat-
terns  in vivo and isolate the particular subset of cells
expressing the candidate genes by using GFP-based cell
sorting. Although we focused on ES cell-specific genes that
are down-regulated during differentiation in this study,
this gene trap system can also be used to identify genes
that are up-regulated during ES cell differentiation (Li and
Leder, unpublished data).
ES cells can be induced to differentiate into many cell lin-
eages [45]. It is possible that some of the ES cell-specific
genes identified in this study may have persistent expres-
sion in lineages which were not contained in the differen-
tiation outcomes observed in this study. In this sense, ES
cell differentiation can mimic many developmental proc-
esses in vivo. It is important to know how the undifferen-
tiated state is maintained in ES cells and what initiates the
decision to differentiate. A good starting point to answer-
ing these questions is to systematically survey ES cell-spe-
cific genes for their roles in maintaining the
undifferentiated state as well as in promoting the differen-
tiation of ES cells.
Methods
ES cell culture
Murine TC1 ES cells were grown on mitomycin C-treated
feeder fibroblast cells. The medium used for undifferenti-
ated ES cells is DMEM (Gibco) supplemented with 15%
fetal bovine serum (Sigma) and 103units/ml Leukemia
Inhibitory Factor (LIF) (Chemicon). To obtain differenti-
ated cells, the same growth medium was used and ES cells
were grown without LIF and feeder fibroblast cells for four
days.
Construction of the gene trap vector
Inverse PCR was used to delete the intervening sequence
in the original RET vector [23], resulting in the fusion of
GFP and Neo reporter genes (Figure 1). The IRES sequence
derived from EMCV was inserted at the junction in front
of the start codon of Neo. The IRES sequence of the cellu-
lar NF-kappaB repressing factor (NRF) gene [46] was first
amplified from a cDNA library by PCR and then placed in-
between the splice acceptor site and GFP reporter.
Retroviral infection and drug selection of ES cells
The gene trap vector was transfected into phoenix viral
packaging cells [24] by using the calcium phosphate pre-
cipitation method. After culturing for 48 hours at 37°C,
the viral supernatant was harvested and filtrated through
0.45 µm filter to remove cell debris. This viral filtrate was
applied directly onto adherent ES cells grown in the pres-
ence of feeder fibroblast cells. G-418 was added to the
medium 24 hours later after viral infection at the final
concentration of 260 µg/ml. ES cells were subjected to the
drug selection for 7 to 10 days until colonies appeared
with a diameter of about 1 mm.
FACS analysis of ES clones
G-418-resistant colonies were individually picked, par-
tially digested with trypsin and transferred to 24-well
plates seeded with feeder fibroblast cells. After growing for
3 to 5 days, half of the ES cells derived from each clone
were frozen as a stock and the rest were split into two wells
of 24-well plates. One portion of the cells was grown in
the medium with feeder fibroblast cells plus LIF and the
other was grown without feeder cells and LIF. After being
cultured for 4 days, ES cells from both undifferentiated
and differentiated populations were harvested for FACS
analysis.
RNA preparation and Northern blot
Trizol reagent (Invitrogen) was used to harvest total RNA
from ES cells. After purification, total RNA was dissolved
in DEPC-treated water. The concentration of RNA was
measured with spectrophotometer and approximately
equal amounts of total RNA for differentiated and undif-
ferentiated samples were loaded for Northern blot analy-
sis.
Total RNA was also prepared from the adult mouse organs
with Trizol reagent.
Amplification of the integration sites and flanking genomic 
sequences by inverse PCR
Genomic DNA was prepared from each candidate ES
clone and subjected to HindIII restriction enzyme diges-
tion. After HindIII was heat-inactivated, the digested
genomic DNA was treated with T4 DNA ligase. The liga-
tion mixture was used directly as the DNA template for the
inverse PCR reactions. Two rounds of the inverse PCR
reactions were performed, with the PCR reaction mixture
from the first round inverse PCR as the template for the
second round inverse PCR by using two nested primers.
The two primers used for the first round inverse PCR reac-
tion are IR(N)-GF1 and U5-R1, with the sequences of 5'-
cctgccacagacttagaatcagcc and 5'-ctcttgcagttgcatccgacttgtg,
respectively. The two primers used for the nested second
round inverse PCR are IR(N)-GF2 and U5-R2, with the
sequences of 5'-ctctaaggaccctgattcc and 5'-gtggtctcgctgttc-
cttg, respectively.BMC Cell Biology 2007, 8:37 http://www.biomedcentral.com/1471-2121/8/37
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RT-PCR analysis of the fusion transcripts
The primer used for the first-strand cDNA synthesis is
Xho-Junc with the sequence of 5'-tcgagccctgagccgta which
is complementary to the sequence at the junction of SA
and I(N) in the gene trap vector eGeoN/E+pA. The reverse
primer used for the PCR reaction is Bcl-2R2 with the
sequence of 5'-ccgtacagttccacaaag which is complemen-
tary to the sequence present in the exon 3 of bcl-2 in the
SA region of the gene trap vector. The forward primers
used for PCR are gene-specific primers derived from
sequences present in the exons of the predicted endog-
enous genes upstream of the gene trap integration sites in
these ES clones. For the ES clone 2G2 and 5C25, it is P1
with the sequence of 5'-tgagaagcccaggcttctctg. For the ES
clone 5C1 and 5C11, they are 5C1-F1 of 5'-agtctcttgccttct-
cagg and 5C11-F1 of 5'-cctttttggaatggagacagcag, respec-
tively.
Semi-quantitative RT-PCR analysis of the different 
isoforms of CSL/RBP-Jkappa
First-strand cDNA template was synthesized from 2 µg
total RNA of undifferentiated wild-type TC1 ES cells by
using Superscript II™ (Invitrogen/Gibco). One-tenth of
the first-strand cDNA mixture was used in the RT-PCR
reactions. Thirty cycles of amplification were performed
with the Advantage GC cDNA polymerase (BD Bio-
sciences Clontech). The primers used are P1 5'-ccttcaaga-
tatccagcaag, P2 5'- cctataggccaacatttgag, P3 5'-
caaacgactcactagggaag, P4 5'- cacagggttgagactcttg and P5 5'-
gtaatgccctccggttttcctc.
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